TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci (Q40760998)

23 September 2017

title

TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci (English)

1 reference

23 September 2017

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Sang Ho Lee

1

1 reference

23 September 2017

Hao Wang

2

1 reference

23 September 2017

Marc Labroli

3

1 reference

23 September 2017

Sandra Koseoglu

4

1 reference

23 September 2017

Paul Zuck

5

1 reference

23 September 2017

Todd Mayhood

6

1 reference

23 September 2017

Charles Gill

7

1 reference

23 September 2017

Paul Mann

8

1 reference

23 September 2017

Xinwei Sher

9

1 reference

23 September 2017

Sookhee Ha

10

1 reference

23 September 2017

Shu-Wei Yang

11

1 reference

23 September 2017

Mihir Mandal

12

1 reference

23 September 2017

Christine Yang

13

1 reference

23 September 2017

Lianzhu Liang

14

1 reference

23 September 2017

Zheng Tan

15

1 reference

23 September 2017

Paul Tawa

16

1 reference

23 September 2017

Yan Hou

17

1 reference

23 September 2017

Reshma Kuvelkar

18

1 reference

23 September 2017

Kristine DeVito

19

1 reference

23 September 2017

Xiujuan Wen

20

1 reference

23 September 2017

Jing Xiao

21

1 reference

23 September 2017

Michelle Batchlett

22

1 reference

23 September 2017

Carl J Balibar

23

1 reference

23 September 2017

Jenny Liu

24

1 reference

23 September 2017

Jianying Xiao

25

1 reference

23 September 2017

Nicholas Murgolo

26

1 reference

23 September 2017

Charles G Garlisi

27

1 reference

23 September 2017

Payal R Sheth

28

1 reference

23 September 2017

Amy Flattery

29

1 reference

23 September 2017

Jing Su

30

1 reference

23 September 2017

Christopher Tan

31

1 reference

23 September 2017

Terry Roemer

32

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2016

1 reference

Science Translational Medicine

23 September 2017

published in

1 reference

23 September 2017

volume

8

1 reference

23 September 2017

issue

329

1 reference

23 September 2017

page(s)

329ra32

1 reference

Antimicrobial resistance: it's not just for hospitals

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Methicillin-resistant Staphylococcus aureus: the European landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Antagonism of chemical genetic interaction networks resensitize MRSA to β-lactam antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Systems-level antimicrobial drug and drug synergy discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Challenges and successes in developing new therapies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Immuno-oncology combinations: a review of clinical experience and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Three decades of beta-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Wall teichoic acid function, biosynthesis, and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

The N-acetylmannosamine transferase catalyzes the first committed step of teichoic acid assembly in Bacillus subtilis and Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Probing teichoic acid genetics with bioactive molecules reveals new interactions among diverse processes in bacterial cell wall biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Taking aim at wall teichoic acid synthesis: new biology and new leads for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

ABC transporters required for export of wall teichoic acids do not discriminate between different main chain polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Teichoic acid biosynthesis as an antibiotic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

The therapeutic journey of benzimidazoles: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Investigational antimicrobial agents of 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Protein glycosylation in yeast: transcript heterogeneity of the ALG7 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Biosynthesis of the tunicamycins: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Crystal Structure of MraY, an Essential Membrane Enzyme for Bacterial Cell Wall Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

The art and design of genetic screens: Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

The zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Late-stage polyribitol phosphate wall teichoic acid biosynthesis in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

Ubiquitous Presence of a mecA Homologue in Natural Isolates of Staphylococcus sciuri

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD7364

10.1126/SCITRANSLMED.AAD7364

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference